VIRX

Viracta Therapeutics, Inc. Common Stock

Delisted

VIRX was delisted on the 3rd of February, 2025.

38 hedge funds and large institutions have $25.4M invested in Viracta Therapeutics, Inc. Common Stock in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 5 closing their positions.

Holders
38
Holders Change
-1
Holders Change %
-2.56%
% of All Funds
0.95%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
8
Reduced
6
Closed
5
Calls
$119K
Puts
Net Calls
+$119K
Net Calls Change
-$541K